Eurofins CDMO, India facility, provides NCE/API development and manufacturing services for complex and niche small molecule programs from preclinical to Phase III and commercial supply
Eurofins understands your need for the right balance of speed and cost with the highest quality and endeavour to develop a partnership that creates mutual success.
The facilities are well equipped and the team has expertise and experience to develop new, safe and efficient synthetic route for complex molecules. Eurofins provide seamless transition from candidate selection to commercialisation. The company offers regulatory-compliant analytical services to support Chemistry and Manufacturing Controls (CMC) requirements.
To support your drug substance requirements, Eurofins services include:
